Physician profile
Sonny Wong
NPI 1457369571
$17,780.77
in general payments reported to CMS, 2019-2025
39 companies · $2,563 in 2025
The $2,563 reported for 2025 was more than what 87% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,593 · 2020: $734 · 2021: $3,958 · 2022: $3,707 · 2023: $2,520 · 2024: $2,706 · 2025: $2,563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,381 · Travel and Lodging: $388 · Education: $20.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,381.30 |
| Travel and Lodging | $387.74 |
| Education | $20.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bard Peripheral Vascular, INC. | $2,152.63 | 2021-2024 | Venclose Maven Catheter |
| Abbott Laboratories | $2,062.54 | 2019-2025 | Jot Dx, Ensite, Aveir |
| Boston Scientific Corporation | $1,677.46 | 2021-2025 | Watchman, Varithena Administration Pack, Watchman Flx |
| Astrazeneca Pharmaceuticals LP | $1,463.22 | 2019-2025 | Farxiga, Wainua, Lokelma |
| Janssen Pharmaceuticals, INC | $1,210.82 | 2019-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $889.09 | 2021-2025 | Verquvo, Capvaxive |
| Novartis Pharmaceuticals Corporation | $782.26 | 2019-2025 | |
| Amgen INC. | $737.02 | 2019-2025 | Repatha, Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $658.75 | 2022-2025 | |
| Medtronic, INC. | $635.57 | 2021-2025 | Venaseal, Micra, Mycarelink |
| Impulse Dynamics (USA) INC. | $529.76 | 2022-2024 | Optimizer, Optimizer |
| Amarin Pharma, INC. | $446.03 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $432.01 | 2019-2025 | Camzyos, Eliquis |
| Esperion Therapeutics, INC. | $383.44 | 2020-2025 | Nexletol |
| Shockwave Medical, INC | $346.84 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $344.32 | 2020-2025 | Lifevest |
| Abiomed | $335.68 | 2024-2025 | Impella |
| Medtronic Vascular, INC. | $321.72 | 2019 | |
| Galderma Laboratories, L.P. | $319.47 | 2019-2025 | Dysport |
| Biotronik INC. | $304.87 | 2019-2021 | |
| Pfizer INC. | $241.11 | 2019-2024 | |
| Philips North America LLC | $216.99 | 2022-2024 | (Ck7) Extended Holter |
| Gilead Sciences, INC. | $188.54 | 2019 | |
| Abbvie INC. | $149.05 | 2024 | |
| Irhythm Technologies, INC. | $139.91 | 2020-2023 | Zio Xt Patch |
| Siemens Medical Solutions USA, INC. | $117.91 | 2023 | Diagnostic Ultrasound System, Artis Q Ceiling, Cios Alpha |
| Kowa Pharmaceuticals America, INC. | $110.11 | 2019-2023 | Seglentis, Livalo |
| Sanofi-Aventis U.S. LLC | $93.75 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $90.83 | 2019-2024 | Evkeeza |
| Boehringer Ingelheim Pharmaceuticals, INC. | $75.81 | 2020-2022 | |
| Allergan, INC. | $73.22 | 2021-2022 | |
| Venclose INC. | $66.21 | 2020 | |
| Scpharmaceuticals INC. | $50.89 | 2023-2024 | |
| Baxter Healthcare | $44.15 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Lilly USA, LLC | $19.13 | 2025 | Zepbound, Mounjaro |
| Medicomp INC | $18.49 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $18.35 | 2023 | Inpefa |
| Inspire Medical Systems, INC. | $17.39 | 2024 | Inspire |
| Novo Nordisk INC | $15.43 | 2025 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonny Wong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.